Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3745656016 | Netarsudil (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3745657013 | Netarsudil | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Netarsudil | Is a | Amino acid | true | Inferred relationship | Some | ||
Netarsudil | Is a | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some | ||
Netarsudil | Has disposition | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Netarsudil only product in ocular dose form | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 1 |
Netarsudil-containing product in ocular dose form | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 1 |
Netarsudil-containing product | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 1 |
Netarsudil only product | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 1 |
Latanoprost- and netarsudil-containing product | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 2 |
Latanoprost and netarsudil only product | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 2 |
Latanoprost- and netarsudil-containing product in parenteral dose form | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 2 |
Latanoprost and netarsudil only product in parenteral dose form | Has active ingredient | True | Netarsudil | Inferred relationship | Some | 2 |
Reference Sets
Substance foundation reference set